Novo Nordisk | driving change to defeat serious chronic diseases
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Novo Nordisk - Wikipedia
Novo Nordisk is the largest pharmaceutical company in Denmark. [14] Novo Nordisk's market capitalization exceeded the GDP of Denmark's domestic economy in 2023, and it is the highest valued company in Europe. [15] Revenue in 2023 was 33.724 billion USD.
Who we are - Novo Nordisk
We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes.
Novo Nordisk to build $1.2B rare disease drug factory in Denmark
Dec 16, 2024 · Novo Nordisk is laying out 8.5 billion Danish kroner (about $1.2 billion) to establish a brand-new manufacturing plant in Odense, Denmark, where the company eventually plans to hire on 400...
Velkommen til Novo Nordisk Danmark
Vi er en global lægemiddelvirksomhed, der blev grundlagt i 1923 med hovedkontor lige uden for København. Vores formål er at drive forandring for at bekæmpe diabetes og andre alvorlige kroniske sygdomme som svær overvægt og sjældne blodsygdomme og endokrine sygdomme.
The single company propping up an entire economy - Financial …
Sep 17, 2023 · London | If you suffer from obesity, Danish pharmaceutical giant Novo Nordisk has two talk-of-the-town drugs, Ozempic and Wegovy, that might be able to help you slim down. But for Denmark as...
Novo Nordisk's market value of $570 billion is now bigger
May 1, 2024 · Novo's enormous scale in Denmark also comes with risks for the company and its home market. “When you have superpowers, you have super responsibility," says CEO Lars Fruergaard Jorgensen.
Novo Nordisk's obesity-fighting drugs fatten Denmark's …
Nov 4, 2024 · Novo Nordisk's blockbuster drugs Ozempic and Wegovy have slimmed down Hollywood stars and millions of non-celebrities worldwide — all while adding great heft to Denmark's economy.
News Details - Novo Nordisk
Nov 9, 2023 · Bagsværd, Denmark, 10 November 2023 – Novo Nordisk today announced plans to invest more than 42 billion Danish kroner starting in 2023 1 to expand existing manufacturing facilities in Kalundborg, Denmark, for the current and future product portfolio within serious chronic diseases.
Novo Nordisk A/S: Semaglutide 7.2 mg s.c. achieved 20.7
1 day ago · Bagsværd, Denmark, 17 January 2025 – Novo Nordisk today announced headline results from STEP UP, a phase 3b trial in the global STEP programme. STEP UP is a 72-week efficacy and safety trial ...